Altered Faecal Protease Activity in Irritable Bowel Syndrome Patients in China
NCT ID: NCT01060527
Last Updated: 2010-02-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2010-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Serine Proteases in Gastrointestinal Function and Irritable Bowel Syndrome (IBS)
NCT01072916
Fecal Amino Acids，Gut Taste Receptors and Irritable Bowel Syndromes
NCT06489444
The Role of Intestinal Inflammation in Irritable Bowel Syndrome (IBS)
NCT01072903
Analysis of Differences in Small Intestinal Microbiota Structure and Metabolites Between Patients With Irritable Bowel Syndrome and Healthy Individuals
NCT07212569
Genetic Determinism of Epithelial Barrier Defects in Irritable Bowel Syndrome
NCT02841878
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IBS-D
No interventions assigned to this group
IBS-C
No interventions assigned to this group
Controll
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xi'an Jiaotong University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
the second affiliated hospital of xi'an jiaotong university
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
xi'an JTU091202
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.